Gamma-secretase inhibitors reverse glucocorticoid resistance in T-ALL

Gamma-secretase inhibitors (GSIs) block the activation of oncogenic NOTCH1 in T-cell acute lymphoblastic leukemia (T-ALL). However, limited antileukemic cytotoxicity and severe gastrointestinal toxicity have restricted the clinical application of these targeted drugs. Here we show that combination t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Real, Pedro J., Tosello, Valeria, Palomero, Teresa, Castillo, Mireia, Hernando, Eva, de Stanchina, Elisa, Sulis, Maria Luisa, Barnes, Kelly, Sawai, Catherine, Homminga, Irene, Meijerink, Jules, Aifantis, Iannis, Basso, Giuseppe, Cordon-Cardo, Carlos, Ai, Walden, Ferrando, Adolfo
Format:	Artigo
Language:	Inglês
Published:	2008
Subjects:	Article
Online Access:	https://ncbi.nlm.nih.gov/pmc/articles/PMC2692090/ https://ncbi.nlm.nih.gov/pubmed/19098907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nm.1900
Tags:	Add Tag No Tags, Be the first to tag this record!

Gamma-secretase inhibitors reverse glucocorticoid resistance in T-ALL

Similar Items